Sabra Health Care REIT, Inc (SBRA) Fair Value & Analysis
Real Estate · US · Market cap $4.6B
Sabra Health Care REIT, Inc
SBRA · US
Fair value as of: Jul 27, 2026
From 16 valuation models · updated 14 days ago
Share price +5.0% over the past month.
A solid business, but screening 50% overvalued on our models.
What matters now
- The price sits above even our optimistic bull case ($13.11). The favourable scenario is already priced in.
- Solid but not exceptional quality (62/100) and above fair value, neither a clear bargain nor a standout compounder.
- As a real-estate business, asset- and dividend-based methods carry more weight here than a standard DCF.
Price vs Fair Value (5 years)
White line = price, green steps = our fair value per fiscal year, dashed = 300-day average. As of Jul 27, 2026.
How to read this chart
60‑month range $7.93 – $22.39 · fair‑value band $8.90 – $13.11 · the $21.04 price screens above the $10.49 fair value. Green steps = our fair value per fiscal year (point-in-time, no hindsight). Dashed = 300-day average. As of Jul 27, 2026.
Analysis
Sabra Health Care REIT, Inc (SBRA) currently trades at $21.04, while our model-based Fair Value estimate is $10.49, implying the stock looks roughly 50.1% overvalued today. The Quality Score stands at 62/100 (solid quality), in the Real Estate sector. Bear case: priced above our estimate, the market already discounts strong expectations. Bull case: above-average quality can justify a premium, the entry price still matters most (evidence: high).
Over the trailing twelve months, Sabra Health Care REIT, Inc generated revenue of $816M at a net margin of 19.2%. Revenue grew 21.7% year over year. It earns a return on equity of 5.7%. Net debt stands at $2.5B. Fundamentals as of Jul 27, 2026
Our scenario range runs from $8.90 (bear case) to $13.11 (bull case); at $21.04, the current price sits above that range. Bear and bull are the same models run on conservative and optimistic assumptions (margins, growth, valuation multiples), so a plausible valuation range, not a price target. The share trades about 1% below its 52-week high and 28% above its 52-week low, currently above its 200-day average. For context, the median of 10 Real Estate peers we cover trades at -48% fair-value upside, at -50%, SBRA screens richer than that median.
Fair Value models
Each model estimates fair value its own way; the Fair Value above is the evidence-weighted blend. Evidence (0–100) measures how completely this model’s inputs are available: well-fed models carry more weight in the blend. The spread across models is intentional, each one stresses a different value driver; dividend models, for instance, come out structurally low when payout is small.
All 16 models by family
Widest divergence: DCF Models ($24.97) versus Asset-Based ($7.50). Highest evidence: Growth DCF (80).
Key figures & financial health
More key figures
Figures from reported company fundamentals · as of Jul 27, 2026. TTM = trailing twelve months.
Quality Score breakdown
Of which business quality 60 · Market factors (momentum, volatility) 70
Non-valuation factor families (profitability, growth, cashflow, financial strength, momentum …), each academically grounded. Valuation itself sits in the Fair Value and is deliberately excluded here to avoid double-counting.
About the company
Sabra Health Care REIT, Inc. operates as a self-administered, self-managed real estate investment trust that, through its subsidiaries, owns and invests in real estate serving the healthcare industry throughout the United States and Canada. Sabra Health Care REIT, Inc. is incorporated on May 10th, 2010 and is based in Tustin, United States.
Company description, as reported by the company or data provider.
Revenue & earnings trend
FY2021 – FY2025 · reported fiscal years
Sabra Health Care REIT, Inc reported revenue of $775M in FY2025 versus $570M in FY2021, a compound +8.0%/yr. Reported net income was $156M in FY2025.
SBRA screens 50% overvalued. Compare with Welltower Inc →
Recent news
External third-party headlines (Yahoo Finance, Reuters and others), not an editorial selection.
- Sabra Health Care REIT (SBRA) Could Be 5% Below Fair Value Following AFFO And Outlook Reaffirmation
- Sabra Health Care REIT Inc (SBRA) (Q2 2026) Earnings Call Highlights: Strong Senior Housing ...
- Sabra Healthcare (SBRA) Tops Q2 FFO and Revenue Estimates
- Sabra Reports Second Quarter 2026 Results; Reiterates 2026 Guidance
Peer Group
REIT - Healthcare Facilities · 28 stocks
How this stock ranks against its industry: the green marker is this stock, the band is the typical 25–75% peer range, and the tick is the median.
Valuation Multiples vs REIT - Healthcare Facilities median · lower = cheaper
Snowflake
Five quick dimensions, each 0 to 100: VALUE (fair-value potential), FUTURE (revenue growth), PAST (return on equity), HEALTH (low debt), DIVIDEND (yield). Green = this stock, grey = typical sector peer.
VALUE 0: the price sits above our fair-value range.
Values & ESG
Does this company touch areas you may want to avoid? The classification is inferred from sector and industry.
ESG scores are not available for this stock yet. Values and ESG data are contextual and can differ between providers.
Similar stocks
10 more REIT - Healthcare Facilities stocks, each showing price versus our Fair Value estimate (as of Jul 27, 2026).
| Stock | Price | Fair Value | vs Fair Value |
|---|---|---|---|
| Welltower Inc WELL | $231.59 | $42.21 | -82% |
| Ventas, Inc VTR | $100.53 | $18.07 | -82% |
| Omega Healthcare Investors, Inc OHI | $51.72 | $33.69 | -35% |
| Healthpeak Properties, Inc DOC | $22.27 | $7.02 | -68% |
| American Healthcare REIT, Inc AHR | $56.38 | $11.04 | -80% |
| CareTrust REIT, Inc CTRE | $43.25 | $23.07 | -47% |
| Healthcare Realty Trust Incorporated HR | $21.40 | $20.60 | -4% |
| Aedifica NV AED | €69.85 | €36.17 | -48% |
| Chartwell Retirement Residences CSHUN | C$22.81 | C$3.52 | -85% |
| National Health Investors, Inc NHI | $80.54 | $49.86 | -38% |
Compare Sabra Health Care REIT, Inc with another stock
Price, fair value, quality and upside side by side.
Explore undervalued stocks
More undervalued Real Estate stocks →
Frequently asked questions
Is Sabra Health Care REIT, Inc (SBRA) overvalued or undervalued?
What is the fair value of SBRA?
What is the quality score of SBRA?
What is the revenue of Sabra Health Care REIT, Inc (SBRA)?
What is the net profit margin of SBRA?
Does Sabra Health Care REIT, Inc pay a dividend?
How we calculate Fair Value
Each company is valued through a stack of independent intrinsic-value models (DCF variants, residual-income, multiples and more), blended into one family-balanced consensus and weighted by how much trustworthy data backs it. A separate quality layer scores the fundamentals. Every input is real reported data, nothing guessed.
Track Sabra Health Care REIT, Inc and try Pro for 14 days
One email gets you 14 days of full Pro (review alerts, the 35,000+ stock screener, the diversification check) plus the monthly Top-25 report of the most undervalued quality stocks. No card, cancel anytime.
Zero risk: nothing is ever charged. After 14 days you decide whether to stay.